MUNICH 2008 - Munich 2008 CINP Biennial International Congress 2008

Website http://cinp.org/index.php?id=79 | Edit Freely

Category MUNICH 2008

Deadline: February 01, 2008 | Date: July 17, 2008

Venue/Country: Munich, Germany

Updated: 2010-06-04 19:32:22 (GMT+9)

Call For Papers - CFP

Munich, Sunday 13th to Thursday 17th July 2008

The XXVI Congress of the CINP is taking place on July 13 -17 2008 in Munich. This is a special event celebrating the 50th Anniversary of the CINP, whose foundation in 1958 marked the beginning of modern psychopharmacology. This will be the leading international psychopharmacology meeting in 2008 with the most important and distinguished psychiatrists and basic scientists from all around the world attending. Munich has been chosen as one of the finest locations to host this great event. The city has a 100-year old relationship with psychiatry, represented by the outstanding researchers and psychiatrists Emil Kraepelin and Alois Alzheimer, who spent a great part of their active lives together at Kraepelin¡¯s Munich Hospital. Furthermore, the city has an outstanding relationship with art and culture. Munich thus offers a unique opportunity to combine all aspects of modern psychiatry with famous art and culture. From the Old Pinakothek up to the recently opened Modern Pinakothek every aspect of art is represented. July, in addition, is the most interesting month of the year, with a number of cultural activities going on such as Open Air Concerts, Biergartens and the famous Opera Festival. With its surrounding lakes and mountains and its numerous cultural attractions, Munich will provide a very exciting venue for the CINP congress delegates.

The Scientific Program will cover all aspects of treatment of CNS disorders from basic to clinical research, and the newest concepts for improving the life of patients with mental and neurological disorders will be presented. There will be plenary lectures, symposia, poster sessions, educational workshops and meet the expert sessions. These will cover the latest research in affective disorders, addiction and dependence, anxiety, psychoses especially schizophrenia, degenerative brain diseases and other key neuropsychopharmacology research topics. The latest advances in brain imaging, genetics and molecular biology will be incorporated within these sessions. How these are being applied to the latest improvements in therapeutics will be covered.

The venue of the congress is the very modern international congress centre in Munich, which has excellent meeting facilities for the delegates. Highly interesting scientific symposia, events and exhibitions will also be organised by pharmaceutical companies, offering new and valuable information to the audience.